Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
3 of 6 columns
Comparison
| Attribute | Agen Genomics, Inc.4.7remove | MalarVx, Inc.4.6remove | Layka Bio Inc4.8remove |
|---|---|---|---|
| Signal scores | |||
| Radar composite | 4.7 | 4.6 | 4.8 |
| IPO signal score | 9.4 | 9.2 | 9.5 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE+3.5 | STABLE+2.6 | STABLE0.0 |
| Company | |||
| Stage | private | private | private |
| Sector | Technology | Technology | Technology |
| Headquarters | ESCONDIDO, United States | SEATTLE, United States | NEWTON HIGHLANDS, United States |
| Founded | 2025 | not on record | 2026 |
| Employees | not on record | not on record | not on record |
| Capital | |||
| Latest valuation | not on record | not on record | not on record |
| Total funding | $25K | $125K | $300K |
| Latest round | Private Placement $25K | Private Placement $125K | Private Placement $300K |
| Investors on record | 0 | 0 | 0 |
| Evidence | |||
| Institutional relationships | 0 | 0 | 0 |
| Active signals | 1 | 1 | 1 |
| Confidence | 53% | 53% | 53% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.